Vyas, Maulik ORCID: 0000-0003-2996-4682, Koehl, Ulrike ORCID: 0000-0002-8159-9160, Hallek, Michael and von Strandmann, Elke Pogge (2014). Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer. Trends Mol. Med, 20 (2). S. 72 - 83. OXFORD: ELSEVIER SCI LTD. ISSN 1471-499X
Full text not available from this repository.Abstract
The insight that the immune system is able to eradicate tumor cells inspired the development of targeted immunotherapies. These novel approaches aim to trigger immune molecules and receptors, including CD3 on T cells and NKG2D and NKp30 on natural killer (NK) cells, to harness the immune system against cancer. In cancer patients, overcoming immune suppression induced by malignant cells or by the tumor microenvironment remains the major challenge to the clinical efficacy of immunotherapies. Recombinant constructs have been developed in various formats either utilizing natural ligands (immunoligands) or antibody-derived components (immunoconstructs) to circumvent mechanisms that counteract an effective antitumor immune response.
Item Type: | Journal Article | ||||||||||||||||||||
Creators: |
|
||||||||||||||||||||
URN: | urn:nbn:de:hbz:38-447055 | ||||||||||||||||||||
DOI: | 10.1016/j.molmed.2013.10.006 | ||||||||||||||||||||
Journal or Publication Title: | Trends Mol. Med | ||||||||||||||||||||
Volume: | 20 | ||||||||||||||||||||
Number: | 2 | ||||||||||||||||||||
Page Range: | S. 72 - 83 | ||||||||||||||||||||
Date: | 2014 | ||||||||||||||||||||
Publisher: | ELSEVIER SCI LTD | ||||||||||||||||||||
Place of Publication: | OXFORD | ||||||||||||||||||||
ISSN: | 1471-499X | ||||||||||||||||||||
Language: | English | ||||||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||||||
Subjects: | no entry | ||||||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/44705 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |